Form 8-K - Current report:
SEC Accession No. 0001558370-24-015706
Filing Date
2024-11-14
Accepted
2024-11-14 16:05:31
Documents
14
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akya-20241114x8k.htm   iXBRL 8-K 43902
2 EX-99.1 akya-20241114xex99d1.htm EX-99.1 298298
  Complete submission text file 0001558370-24-015706.txt   484413

Data Files

Seq Description Document Type Size
3 EX-101.SCH akya-20241114.xsd EX-101.SCH 3413
4 EX-101.LAB akya-20241114_lab.xml EX-101.LAB 16584
5 EX-101.PRE akya-20241114_pre.xml EX-101.PRE 10460
16 EXTRACTED XBRL INSTANCE DOCUMENT akya-20241114x8k_htm.xml XML 5092
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 241461899
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)